Herborium Group, Inc. (HBRM)
- Previous Close
0.0001 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0001 - 52 Week Range
0.0000 - 0.0002 - Volume
2,100,000 - Avg. Volume
2,787,807 - Market Cap (intraday)
2,202 - Beta (5Y Monthly) 65.81
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Feb 15, 2024 - Feb 19, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. It offers dermatology products, which include AcnEase, herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company also provides sexual health and performance products that are non-prescriptive alternatives to selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, and surgical procedures, including hysterectomy. In addition, it offers energy restoration products, such as Lasting Energy, a herbal supplement to decrease the symptoms associated with hangovers and eliminating jet-lag; and for treating overall depletion of energy due to competitive sports, high levels of stress, and extensive sexual activities, as well as other long term or temporary physical demands. Further, the company provides Liver Activator Series for the treatment of liver damage; ProstAid, a natural product focuses on Benign Prostate Hyperplasia; and CardioVitae, a fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. Herborium Group, Inc. sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey.
www.herborium.com2
Full Time Employees
November 30
Fiscal Year Ends
Sector
Recent News: HBRM
Performance Overview: HBRM
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HBRM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HBRM
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
0.43
Enterprise Value/EBITDA
-0.30
Financial Highlights
Profitability and Income Statement
Profit Margin
26.32%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
259.1k
Net Income Avi to Common (ttm)
68.2k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
120.1k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--